For the last ten years Daniel has worked in various TMF roles for both large pharma companies and small biotech, with a full-service CRO and a specialist TMF provider. Having seen the issues from all sides he is a convert to the idea that the TMF is a key part of a quality approach to clinical trial management. He was very involved with the development of subartifacts in the TMF Reference Model and is excited to see and talk about how companies make use of the changes to deliver better quality TMFs and better oversight.
Complete the short form below to register for FREE. All fields indicated with an * are required.